EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up

Sergio López-Tejero iD, Pablo Antúnez-Muiños iD, Pilar Fraile-Gómez, Gilles Barreira-de Sousa, Javier Rodríguez-Collado, Jesús Herrero-Garibi iD, Fabián Blanco-Fernández, Alejandro Diego-Nieto, Gonzalo C Delgado-Lapeira, M Candelas Pérez Del Villar-Moro, Javier Martín-Moreiras, Pedro L Sánchez-Fernández and 1 more

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.30946 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2024. Written by Sergio López-Tejero and 12 co-authors. Institution: Department of Cardiology, Complejo asistencial universitario de Salamanca (CAUSA), Salamanca, Spain. Major MEDLINE topics: Atrial Appendage, Stroke, Renal Insufficiency, Chronic, Atrial Fibrillation. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction and Objectives Advanced chronic kidney disease (A‐CKD) combined with atrial fibrillation increases the risk of both thrombogenic and bleeding events. Left atrial appendage occlusion (LAAO) may be an alternative to oral anticoagulation to prevent thromboembolic events. We aimed to evaluate the outcomes of LAAO in patients with A‐CKD. Methods Comparison at long‐term follow‐up of patients diagnosed with and without A‐CKD (eGFR

Subjects

MeSH terms (MEDLINE)

Atrial AppendageStrokeRenal Insufficiency, ChronicAtrial FibrillationHumansFollow-Up StudiesTreatment OutcomeHemorrhageAnticoagulants

Author keywords

atrial fibrillationchronic kidney failurehigh bleeding riskhigh thrombogenic riskleft atrial appendage occlusionstroke risk

Substances

Anticoagulants

Authors and institutions

  • Department of Cardiology, Complejo asistencial universitario de Salamanca (CAUSA), Salamanca, Spain.
  • Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Spain.
  • Department of Nephrology, Complejo asistencial universitario de Salamanca (CAUSA), Salamanca, Spain.

ORCID profiles: Sergio López-Tejero, Pablo Antúnez-Muiños, Jesús Herrero-Garibi

Cite

APA

López-Tejero, S., Antúnez-Muiños, P., Fraile-Gómez, P., Sousa, G. B., Rodríguez-Collado, J., Herrero-Garibi, J., Blanco-Fernández, F., Diego-Nieto, A., Delgado-Lapeira, G. C., Del Villar-Moro, M. C. P., Martín-Moreiras, J., Sánchez-Fernández, P. L., & Cruz-González, I. (2024). Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30946

Vancouver

López-Tejero S, Antúnez-Muiños P, Fraile-Gómez P, Sousa GB, Rodríguez-Collado J, Herrero-Garibi J, et al. Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30946

BibTeX
@article{LpezTejero2024,
  author = {López-Tejero, Sergio and Antúnez-Muiños, Pablo and Fraile-Gómez, Pilar and Sousa, Gilles Barreira-de and Rodríguez-Collado, Javier and Herrero-Garibi, Jesús and Blanco-Fernández, Fabián and Diego-Nieto, Alejandro and Delgado-Lapeira, Gonzalo C and Del Villar-Moro, M Candelas Pérez and Martín-Moreiras, Javier and Sánchez-Fernández, Pedro L and Cruz-González, Ignacio},
  title = {Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.30946}
}
Start for free →